The Sickle Cell and Red Cell Disorders Curative Therapy Center (CuRED) at Children’s Hospital of Philadelphia (CHOP) is the first clinical center in the United States to offer family-focused care to help patients with red blood cell disorders on the journey from chronic disease to cure.

The clinic draws on the expertise of four CHOP programs that are critical to the care of children with red blood cell disorders:

• The Comprehensive Sickle Cell Center (CSCC) is one of the nation's largest pediatric sickle cell centers, caring for over 1,000 children, adolescents and young adults. The CSCC collaborates with the Hospital of the University of Pennsylvania and Pennsylvania Hospital in the care of an additional 400 adult patients.
• The Thalassemia Program provides complete care to patients with thalassemia syndromes, including those with transfusion-dependent beta thalassemia. It partners with the Adult Thalassemia Program at Penn in caring for adults with severe beta thalassemia.
• The Cell Therapy and Transplant Section (CTTS) has developed innovative stem cell therapies to cure pediatric patients with cancer and severe non-malignant diseases. The section has a world-renowned team of specialists in bone marrow transplant, which is how curative gene therapies are delivered.
• The Fertility Preservation Program guides the families of children with many different diseases when treatment puts their fertility at risk. They help families understand fertility preservation options, both standard and experimental.

We have unmatched expertise and the entire possible range of treatment options.

• CHOP partners with primary care providers nationwide. Patients do not need to live in the Philadelphia area to receive our comprehensive care. Our team provides extensive support to families who want to travel to Philadelphia.
• The most cutting-edge curative therapies for red blood cell disorders are available through clinical trials or approved treatments at CHOP
• Every patient receives customized care when they come to CHOP. Whether or not they can receive curative therapies, each will receive a personalized roadmap for their care.
• We are one of the few centers offering multiple treatment options for patients.
• We have world-leading, established centers for care for sickle cell disease and thalassemia.
• CHOP has been committed to sickle cell research and care since the 1970s, longer than any other institution in the country.

Some of the most significant breakthroughs in treating red cell disorders have happened here. We will support your family in every way as you decide which treatment path is right for your child.